Boehringer Ingelheim Recalls SPIRIVA HandiHaler Due to Failed Stability Specifications
Boehringer Ingelheim is recalling SPIRIVA HandiHaler (tiotropium bromide) capsules because they failed stability specifications. The recall affects 45,008 units distributed nationwide.
- Product
- SPIRIVA — SPIRIVA (TIOTROPIUM BROMIDE)
- Category
- Drug
- Distribution
- Distributed nationwide